SMTL ID : 5j5r.1

M. thermoresistible GuaB2 delta-CBS in complex with inhibitor VCC234718

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

homo-tetramer

Ligands

4 x 6G1: cyclohexyl{4-[(isoquinolin-5-yl)sulfonyl]piperazin-1-yl}methanone(Non-covalent)

6G1.1: 13 residues within 4Å: Chain A: A.145, G.194, V.195, G.196, T.203, M.284, G.285, E.318 Chain C: P.46, A.343, G.346, Y.347 Ligands: IMP.2 7 PLIP interactions: 3 interactions with chain A, 4 interactions with chain C Hydrophobic interactions: A:A.145, C:P.46, C:A.343, C:Y.347, C:Y.347 Hydrogen bonds: A:G.196 Salt bridges: A:E.318 6G1.3: 13 residues within 4Å: Chain B: A.145, G.194, V.195, G.196, T.203, M.284, G.285, E.318 Chain D: P.46, A.343, G.346, Y.347 Ligands: IMP.4 7 PLIP interactions: 4 interactions with chain D, 3 interactions with chain B Hydrophobic interactions: D:P.46, D:A.343, D:Y.347, D:Y.347, B:A.145 Hydrogen bonds: B:G.196 Salt bridges: B:E.318 6G1.5: 13 residues within 4Å: Chain B: P.46, A.343, G.346, Y.347 Chain C: A.145, G.194, V.195, G.196, T.203, M.284, G.285, E.318 Ligands: IMP.6 7 PLIP interactions: 3 interactions with chain C, 4 interactions with chain B Hydrophobic interactions: C:A.145, B:P.46, B:A.343, B:Y.347, B:Y.347 Hydrogen bonds: C:G.196 Salt bridges: C:E.318 6G1.7: 13 residues within 4Å: Chain A: P.46, A.343, G.346, Y.347 Chain D: A.145, G.194, V.195, G.196, T.203, M.284, G.285, E.318 Ligands: IMP.8 7 PLIP interactions: 4 interactions with chain A, 3 interactions with chain D Hydrophobic interactions: A:P.46, A:A.343, A:Y.347, A:Y.347, D:A.145 Hydrogen bonds: D:G.196 Salt bridges: D:E.318

4 x IMP: INOSINIC ACID(Non-covalent)

IMP.2: 21 residues within 4Å: Chain A: S.68, M.70, N.173, G.198, S.199, I.200, C.201, D.234, G.235, G.236, M.255, G.257, S.258, Y.281, G.283, M.284, G.285, S.286, E.318, G.319 Ligands: 6G1.1 17 PLIP interactions: 17 interactions with chain A Hydrogen bonds: A:S.68, A:N.173, A:S.199, A:D.234, A:G.236, A:L.237, A:G.257, A:S.258, A:Y.281, A:M.284, A:G.285, A:S.286 Water bridges: A:G.198, A:S.199, A:G.235, A:L.237, A:L.237 IMP.4: 21 residues within 4Å: Chain B: S.68, M.70, N.173, G.198, S.199, I.200, C.201, D.234, G.235, G.236, M.255, G.257, S.258, Y.281, G.283, M.284, G.285, S.286, E.318, G.319 Ligands: 6G1.3 17 PLIP interactions: 17 interactions with chain B Hydrogen bonds: B:S.68, B:N.173, B:S.199, B:D.234, B:G.236, B:L.237, B:G.257, B:S.258, B:Y.281, B:M.284, B:G.285, B:S.286 Water bridges: B:G.198, B:S.199, B:G.235, B:L.237, B:L.237 IMP.6: 21 residues within 4Å: Chain C: S.68, M.70, N.173, G.198, S.199, I.200, C.201, D.234, G.235, G.236, M.255, G.257, S.258, Y.281, G.283, M.284, G.285, S.286, E.318, G.319 Ligands: 6G1.5 17 PLIP interactions: 17 interactions with chain C Hydrogen bonds: C:S.68, C:N.173, C:S.199, C:D.234, C:G.236, C:L.237, C:G.257, C:S.258, C:Y.281, C:M.284, C:G.285, C:S.286 Water bridges: C:G.198, C:S.199, C:G.235, C:L.237, C:L.237 IMP.8: 21 residues within 4Å: Chain D: S.68, M.70, N.173, G.198, S.199, I.200, C.201, D.234, G.235, G.236, M.255, G.257, S.258, Y.281, G.283, M.284, G.285, S.286, E.318, G.319 Ligands: 6G1.7 17 PLIP interactions: 17 interactions with chain D Hydrogen bonds: D:S.68, D:N.173, D:S.199, D:D.234, D:G.236, D:L.237, D:G.257, D:S.258, D:Y.281, D:M.284, D:G.285, D:S.286 Water bridges: D:G.198, D:S.199, D:G.235, D:L.237, D:L.237

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Singh, V. et al., The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis. ACS Infect Dis (2017)

Release Date

2016-10-19

Peptides

Inosine-5'-monophosphate dehydrogenase,Inosine-5'-monophosphate dehydrogenase: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

D
A

Inosine-5'-monophosphate dehydrogenase,Inosine-5'-monophosphate dehydrogenase

Related Entries With Identical Sequence